Both in Pharmaceuticals
Amphastar Pharmaceuticals vs Janux Therapeutics
Over the past year AMPH returned +7.2% and JANX returned −34.9%; their daily moves had a correlation of 0.12.
AMPH +7.2% JANX −34.9%Growth of $1, one year, split-adjusted
| Metric | AMPH | JANX |
|---|---|---|
| Price | $27.12 | $17.82 |
| Market cap | $1.15B | $1.09B |
| Today | +0.33% | +2.06% |
| 1 month | +6.9% | +7.7% |
| 6 months | +15.9% | +24.4% |
| Year to date | +1.3% | +29.1% |
| 1 year | +6.4% | −37.9% |
| Revenue growth (YoY) | +5.4% | — |
| Gross margin | 50.8% | 100.0% |
| Net margin | 16.5% | −214.0% |
| P/E (TTM) | 14.7× | — |
| Price / sales | 1.6× | 45.4× |
| Net cash | -$321.9M | $970.9M |
| Dividend yield | — | — |
| Volatility (60d) | 30.7% | 47.7% |
| Short % of float | 14.9% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).